Yantai Dongcheng Pharmaceutical Co Ltd Financial Flexibility Index
Yantai Dongcheng Pharmaceutical Co Ltd financial flexibility index. Yantai Dongcheng Pharmaceutical Co Ltd (002675) has a Financial Flexibility Index of 0.11x as of December 2025. Free cash flow of CN¥398.23 Million (operating CF CN¥239.54 Million minus capex CN¥158.69 Million) represents 0% of total liabilities (CN¥3.61 Billion). Explore Yantai Dongcheng Pharmaceutical Co Ltd (002675) capital reinvestment to see what proportion of operating cash flow is directed to capital expenditures.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Financial Flexibility Index of Yantai Dongcheng Pharmaceutical Co Ltd (2008–2025)
Financial flexibility index of Yantai Dongcheng Pharmaceutical Co Ltd from 2008 to 2025. Historical Financial Flexibility Index trend for Yantai Dongcheng Pharmaceutical Co Ltd across 18 annual periods. Check Yantai Dongcheng Pharmaceutical Co Ltd cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Yantai Dongcheng Pharmaceutical Co Ltd Financial Flexibility Index by Year (2008–2025)
Yantai Dongcheng Pharmaceutical Co Ltd financial flexibility index by year from 2008 to 2025. Year-by-year free cash flow to debt coverage for Yantai Dongcheng Pharmaceutical Co Ltd. For the full cash flow conversion analysis, see 002675 cash flow conversion.
| Year | Flexibility Index | Free Cash Flow (CNY) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.26x | CN¥945.43 Million | CN¥584.61 Million | CN¥3.61 Billion | ▲ +15.1% |
| 2024 | 0.23x | CN¥743.25 Million | CN¥287.15 Million | CN¥3.26 Billion | ▼ -22.4% |
| 2023 | 0.29x | CN¥788.89 Million | CN¥276.94 Million | CN¥2.69 Billion | ▼ -38.7% |
| 2022 | 0.48x | CN¥1.39 Billion | CN¥996.54 Million | CN¥2.89 Billion | ▼ -14.5% |
| 2021 | 0.56x | CN¥1.47 Billion | CN¥943.58 Million | CN¥2.63 Billion | ▲ +62.8% |
| 2020 | 0.34x | CN¥834.76 Million | CN¥572.58 Million | CN¥2.43 Billion | ▼ -8.6% |
| 2019 | 0.38x | CN¥946.45 Million | CN¥696.38 Million | CN¥2.52 Billion | ▲ +44.4% |
| 2018 | 0.26x | CN¥614.12 Million | CN¥493.06 Million | CN¥2.36 Billion | ▲ +46.5% |
| 2017 | 0.18x | CN¥352.86 Million | CN¥208.94 Million | CN¥1.98 Billion | ▼ -35.7% |
| 2016 | 0.28x | CN¥327.45 Million | CN¥196.28 Million | CN¥1.18 Billion | ▼ -42.0% |
| 2015 | 0.48x | CN¥148.73 Million | CN¥66.69 Million | CN¥311.94 Million | ▼ -15.9% |
| 2014 | 0.57x | CN¥118.50 Million | CN¥52.00 Million | CN¥209.06 Million | ▼ -52.7% |
| 2013 | 1.20x | CN¥152.53 Million | CN¥-20.60 Million | CN¥127.18 Million | ▼ -25.0% |
| 2012 | 1.60x | CN¥116.50 Million | CN¥44.53 Million | CN¥72.84 Million | ▲ +50.0% |
| 2011 | 1.07x | CN¥156.55 Million | CN¥138.83 Million | CN¥146.82 Million | ▲ +145.3% |
| 2010 | 0.43x | CN¥73.07 Million | CN¥57.02 Million | CN¥168.14 Million | ▲ +1913.7% |
| 2009 | -0.02x | CN¥-3.03 Million | CN¥-26.60 Million | CN¥126.53 Million | ▼ -105.9% |
| 2008 | 0.40x | CN¥46.87 Million | CN¥41.57 Million | CN¥115.74 Million | — |